Reacción #89835

ord-4d9bfd94fae54af5a79255f6e080a2cb

Ecuación de reacción

[Cl-]
chloride
CCN(CC)CC
Et3N
CC(C)(C)OC(=O)n1ncc2cc(Nc3nc(-c4cccc(N)c4)nc4ccccc34)ccc21
tert-butyl 5-(2-(3-aminophenyl)quinazolin-4-ylamino)-1H-indazole-1-carboxylate
O=C(Cl)N1CCOCC1
morpholine-4-carbonyl chloride
O=C(Cl)N1CCOCC1
morpholine-4-carbonyl chloride
CCN(CC)CC
Et3N
CCN(CC)CC
Et3N
CC(C)(C)OC(=O)n1ncc2cc(Nc3nc(-c4cccc(NC(=O)N5CCOCC5)c4)nc4ccccc34)ccc21
tert-butyl 5-(2-(3-(morpholine-4-carboxamido)phenyl)quinazolin-4-ylamino)-1H-indazole-1-carboxylate

Disolventes

Condiciones de reacción

Condiciones detalladas
See reaction.notes.procedure_details.

Tratamiento posterior

  1. 1
    workup.ADDITIONwere added
  2. 2
    workup.ADDITIONwere added
  3. 3
    ConcentraciónThe reaction was concentrated in vacuo
  4. 4
    Otrothe residue was purified by flash chromatography on silica (12:1 CH2Cl2:MeOH)

Procedimiento

To a suspension of tert-butyl 5-(2-(3-aminophenyl)quinazolin-4-ylamino)-1H-indazole-1-carboxylate (100 mg, 0.22 mmol) and morpholine-4-carbonyl chloride (51 μL, 0.44 mmol,) in CH2Cl2 (2 mL) was added Et3N (61 μL, 0.44 mmol) and catalytic amount of DMAP. The reaction mixture was stirred at RT for 2 h after which 2 equivalents each of morpholine-4-carbonyl chloride and Et3N were added. After 2 h of stirring another 2 equivalents of both the chloride and Et3N were added and continued to stir at ambient temperature for 16 hours. The reaction was concentrated in vacuo and the residue was purified by flash chromatography on silica (12:1 CH2Cl2:MeOH). The product tert-butyl 5-(2-(3-(morpholine-4-carboxamido)phenyl)quinazolin-4-ylamino)-1H-indazole-1-carboxylate was isolated. (80 mg, 65%)

Fuente

DOI: 10.6084/m9.figshare.5104873.v1Patente: US09440961B2uspto-grants-2016_09